NOS1AP and ventricular fibrillation: Recently, genome-wide association studies have found a common variant in the nitric oxide synthase 1 adaptor protein (NOS1AP) to be associated with QT-interval variation [76] but increased risk for ventricular fibrillation and sudden death could not yet be established [77].